Precursors / Bayer Schering AG
Bayer Schering AG
Cited as Berlin, Germany
- Syntheses citing them
- 2
- Distinct agents
- 1
- Distinct precursors
- 2
From the literature
Precursors named in the literature
Names as written by the authors. Grade, packaging and current availability are not published and have to be confirmed with the supplier.
Where they were used
| Agent | Precursor | Module | Purification | Source |
|---|---|---|---|---|
| [90Y]Y-ibritumomab | Ibritumomab tiuxetan | Manual synthesis | — | 22218876 2012 Eur J Nucl Med Mol Imaging |
| [90Y]Y-ibritumomab | ibritumomab tiuxetan | Kit-based preparation | — | 20616907 2009 Onco Targets Ther |
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from Bayer Schering AG itself.
Need this precursor?We can point you to suppliers for Bayer Schering AG, or handle the enquiry for you.
Get in touch